FrancophonIA/ELRC3.0 huggingface dataset:
English: Potent inhibitors of CYP3A4 (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, telithromycin, nefazodone and HIV protease inhibitors) are likely to markedly increase plasma levels of budesonide and concomitant use should be avoided.
Croatian: Potentni inhibitori CYP3A4 (npr. ketokonazol, itrakonazol, vorikonazol, pozakonazol, klaritromicin, telitromicin, nefazodon i inhibitori HIV proteaze) vjerojatno će značajno povisiti razine budezonida u plazmi pa se istodobna primjena mora izbjegavati.
English: Your doctor may also prescribe another bronchodilator medicine, for example an anticholinergic (such as tiotropium or ipratropium bromide) for your COPD disease.
Croatian: Vaš liječnik može Vam propisati i drugi bronhodilatirajući lijek, primjerice antikolinergik (poput tiotropija ili ipratropij bromida) za liječenje KOPB.
English: If your doctor feels that you need a lower dose than is available from your Budesonide/Formoterol Teva, your doctor may prescribe an alternative inhaler containing the same active substances as your Budesonide/Formoterol Teva but with a lower dose of the corticosteroid.
Croatian: Ako Vaš liječnik smatra da trebate nižu dozu od one koja je dostupna iz Vašeg inhalatora Budezonid/Formoterol Teva, liječnik Vam može propisati zamjenski inhalator koji sadrži iste djelatne tvari kao Vaš Budezonid/Formoterol Teva, no s nižom dozom kortikosteroida.
English: Other possible side effects: Common: may affect up to 1 in 10 people
Croatian: Ostale moguće nuspojave: Često: mogu se javiti kod do 1 na 10 osoba
English: Patients should also be advised to rinse their mouth with water after inhaling (see section 4.4) The patient may notice a taste when using Budesonide/Formoterol Teva due to the lactose excipient.
Croatian: Bolesnicima se također mora savjetovati da nakon inhalacije isperu usta vodom (vidjeti dio 4.4) Bolesnik kod primjene lijeka Budezonid/Formoterol
English: The mean number of days on oral corticosteroids/patient during the 12 months was slightly reduced in the budesonide/formoterol group (7-8 days/patient/year compared with 11-12 and 9-12 days in the placebo and formoterol groups, respectively).
Croatian: Srednja vrijednost broja dana liječenja oralnim kortikosteroidima/bolesniku tijekom 12 mjeseci blago je smanjena u skupini liječenoj kombinacijom budezonida/formoterola (7-8 dana/bolesniku/godišnje u usporedbi s 11-12 i 9-12 dana u skupinama s placebom, odnosno formoterolom).
English: Serious asthma-related adverse reactions and exacerbations may occur during treatment with Budesonide/Formoterol Teva.
Croatian: Ozbiljne nuspojave povezane s astmom i egzacerbacije mogu se pojaviti tijekom liječenja lijekom Budezonid/Formoterol Teva.
English: Potential effects on bone density should be considered, particularly in patients on high doses for prolonged periods that have co-existing risk factors for osteoporosis.
Croatian: Mora se uzeti u obzir potencijalne učinke na gustoću kostiju, poglavito u bolesnika koji primaju visoke doze kroz dulje vrijeme, a istodobno imaju čimbenike rizika za osteoporozu.
English: Use your Budesonide/Formoterol Teva every day.
Croatian: Svakodnevno koristite Budezonid/Formoterol Teva.
English: - The active substances are budesonide and formoterol fumarate dihydrate.
Croatian: - Djelatne tvari su budezonid i formoterolfumarat dihidrat.
English: • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking Budesonide/Formoterol Teva - do NOT use this medicine unless your doctor tells you to.
Croatian: • Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku, ljekarniku ili medicinsku sestru za savjet prije nego uzmete Budezonid/Formoterol Teva - NEMOJTE koristiti ovaj lijek ako Vam to ne odredi vaš liječnik.
English: • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor,pharmacist or nurse for advice before taking Budesonide/Formoterol Teva - do NOT use this medicine unless your doctor tells you to.
Croatian: • Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku, ljekarniku ili medicinskoj sestri za savjet prije nego uzmete Budezonid/Formoterol Teva - NEMOJTE koristiti ovaj lijek ako Vam to ne odredi vaš liječnik.
English: In two 12-month studies, the effect on lung function and the rate of exacerbation (defined as courses of oral steroids and/or course of antibiotics and/or hospitalisations) in patients with severe COPD was evaluated.
Croatian: U dva ispitivanja u trajanju od 12 mjeseci, kod bolesnika s teškom KOPB, procijenjen je učinak na plućnu funkciju i stopu egzacerbacije (definirana kao liječenje peroralnim steroidima i/ili liječenja antibioticima i/ili hospitalizacije).
English: Talk to your doctor,pharmacist or nurse before taking Budesonide/Formoterol Teva if
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primijenite Budezonid/Formoterol
English: Mild irritation in the throat, coughing, hoarseness Bronchospasm
Croatian: Blaga iritacija grla, kašalj, promuklost
English: If you feel you are getting breathless or wheezy while using Budesonide/Formoterol Teva, you should continue to use Budesonide/Formoterol Teva but go to see your doctor as soon as possible, as you may need additional treatment.
Croatian: Ako osjećate da Vam nedostaje zraka ili da Vam zviždi u plućima tijekom primjene inhalatora Budezonid/Formoterol Teva, trebate nastaviti s primjenom inhalatora Budezonid/Formoterol Teva, no ipak se što prije javite svojem liječniku jer će Vam možda biti potrebno dodatno liječenje.
English: Budesonide/Formoterol Teva should be used correctly in order to achieve effective treatment.
Croatian: Teva se mora koristiti pravilno kako bi se postiglo učinkovito liječenje.
English: What you need to know before you use Budesonide/Formoterol Teva Do not use Budesonide/Formoterol Teva if:
Croatian: Što morate znati prije nego počnete primjenjivati Budezonid/Formoterol Teva Nemojte primjenjivati Budezonid/Formoterol
English: Budesonide/Formoterol Teva 160 mcg/4.5 mcg
Croatian: Teva 160 mcg/4,5 mcg
English: Budesonide/Formoterol Teva should be discontinued immediately, the patient should be assessed and an alternative therapy is instituted if necessary (see section 4.4).
Croatian: Teva se mora trenutno prekinuti, bolesnika se mora procijeniti , te po potrebi, treba mu uvesti drugu terapiju (vidjeti dio 4.4).
English: Budesonide/Formoterol Teva contains two different active substances: budesonide and formoterol fumarate dihydrate.
Croatian: Teva sadrži dvije različite djelatne tvari: budezonid i formoterolfumarat dihidrat.
English: You might experience symptoms such as a stuffy or runny nose, weakness or joint or muscle pain and rash (eczema).
Croatian: Možda ćete imati simptome poput začepljenog nosa ili curenja iz nosa, slabosti ili bolova u zglobovima ili mišićima i osipa (ekcem).
English: Contents of the pack and other information What Budesonide/Formoterol Teva contains
Croatian: Sadržaj pakiranja i druge informacije Što Budezonid/Formoterol
English: The dosage of Budesonide/Formoterol Teva is individual and should be adjusted to the severity of the disease.
Croatian: Teva je individualno i mora se prilagoditi težini bolesti.
English: Budesonide/Formoterol Teva is not likely to affect your ability to drive or to use tools or machines.
Croatian: Teva vjerojatno neće utjecati na Vašu sposobnost upravljanja vozilima, alatima ili strojevima.
English: Budesonide/Formoterol Teva 320 micrograms/9 micrograms should be used as maintenance therapy only.
Croatian: Teva od 320 mikrograma/9 mikrograma treba koristiti samo kao terapiju održavanja.
English: If any of the following happen to you, stop using Budesonide/Formoterol Teva and talk to your doctor immediately:
Croatian: Ako vam se dogodi išta od navedenog, prekinite s primjenom lijeka Budezonid/Formoterol Teva i odmah se javite liječniku:
English: Budesonide/Formoterol Teva has no or negligible influence on the ability to drive and use machines.
Croatian: Teva ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Preparing your new Budesonide/Formoterol Teva
Croatian: Priprema Vašeg novog inhalatora Budezonid/Formoterol Teva
English: If you stop using Budesonide/Formoterol Teva
Croatian: Ako prestanete primjenjivati Budezonid/Formoterol Teva
English: The use of Budesonide/Formoterol Teva follows three simple steps: open, breathe and close which are outlined below.
Croatian: Teva slijedi tri jednostavna koraka: otvorite, udahnite i zatvorite kako je navedeno u nastavku.
English: Asthma Budesonide/formoterol maintenance therapy
Croatian: Astma Terapija održavanja budezonidom/formoterolom
English: • Use Budesonide/Formoterol Teva every day.
Croatian: • Svakodnevno koristite Budezonid/Formoterol Teva.
English: If you forget to use Budesonide/Formoterol Teva
Croatian: Ako ste zaboravili primijeniti Budezonid/Formoterol Teva
English: Teva Pharma B.V., Swensweg 5, 2031GA Haarlem,The Netherlands
Croatian: Teva Pharma B.V., Swensweg 5, 2031GA Haarlem, Nizozemska
English: Budesonide/Formoterol Teva pharmacokinetic profile
Croatian: Farmakokinetički profil lijeka Budezonid/Formoterol Teva
English: Budesonide/Formoterol Teva is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:
Croatian: Teva je indiciran u redovitom liječenju astme kad je primjereno kombinirano liječenje (inhalacijskim kortikosteroidom i dugodjelujućim agonistima ß2-adrenergičkih receptora):
English: If either of these symptoms occur, stop using Budesonide/Formoterol Teva straightaway and use your ‘reliever inhaler'.
Croatian: Ako se pojavi bilo koji od ovih simptoma odmah prekinite s primjenom lijeka Budezonid/Formoterol Teva i primijenite svoj „inhalator za brzo ublažavanje simptoma“.
English: Since Budesonide/Formoterol Teva contains both budesonide and formoterol, the same pattern of adverse reactions as reported for these substances may occur.
Croatian: Teva sadrži i budezonid i formoterol, može se pojaviti isti obrazac nuspojava koji je primijećen za te dvije tvari.
English: Once your asthma is well controlled your doctor may consider it appropriate to gradually reduce the dose of Budesonide/Formoterol Teva.
Croatian: Kad su simptomi astme dobro kontrolirani, Vaš liječnik će možda smatrati da je prikladno postupno smanjivati dozu lijeka Budezonid/Formoterol Teva.
English: • Increased mucus production, change in mucus colour
Croatian: • pojačano lučenje sluzi, promjena boje sluzi
English: COPD
Croatian: KOPB
English: A randomised, open-label placebo study was performed in children and adolescents with asthma (aged 6-17 years), adults with asthma (aged 18-45 years), adults with chronic obstructive pulmonary disease (COPDaged >50 years) and healthy volunteers (aged 18-45 years) to evaluate the peak inspiratory flow rate (PIFR) and other related inhalation parameters following inhalation from a Spiromax device (containing placebo) compared with inhalation from an already marketed multi-dose dry powder inhaler device(containing placebo).
Croatian: Randomizirano, otvoreno ispitivanje s placebom provedeno je na djeci i adolescentima s astmom (u dobi od 6-17 godina), odraslima s astmom (u dobi od 18- 45 godina), odraslima s kroničnom opstruktivnom plućnom bolesti (KOPB - u dobi > 50 godina) i zdravim dobrovoljcima (u dobi od 1845 godina) za procjenu brzine vršnog inspiratornog protoka (eng. peak inspiratory flow rate, PIFR) i
English: Possible systemic effects include Cushing´s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma.
Croatian: Mogući sistemski učinci uključuju Cushingov sindrom, Cushingoidna obilježja, adrenalnu supresiju, zastoj u rastu djece i adolescenata, smanjenje mineralne gustoće kosti, kataraktu i glaukom.
English: Patients should not be initiated on Budesonide/Formoterol Teva during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma.
Croatian: Teva tijekom egzacerbacije, niti tijekom značajnog ili akutnog pogoršanja astme.
English: How to use Budesonide/Formoterol Teva
Croatian: Kako primjenjivati Budezonid/Formoterol Teva
English: If Budesonide/Formoterol Teva therapy has to be withdrawn due to overdose of the formoterol component of the medicinal product, provision of appropriate inhaled corticosteroid therapy must be considered.
Croatian: Teva mora prekinuti zbog predoziranja komponentom formoterola u lijeku, mora se razmotriti primjena odgovarajuće terapije inhalacijskim kortikosteroidom.
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients
Croatian: FARMACEUTSKI PODACI 6.1 Popis pomoćnih tvari laktoza hidrat
English: Budesonide/Formoterol Teva is not an appropriate treatment for the adult patient with only mild asthma who is not adequately controlled with an inhaled corticosteroid and “as needed” inhaled short-acting β2 adrenoreceptor agonists.
Croatian: Teva nije odgovarajuće liječenje za odraslog bolesnika koji ima samo blagi oblik astme i koji nije zadovoljavajuće kontroliran inhalacijskim kortikosteroidom i ″prema potrebi″ inhalacijskim ß2-adrenoreceptorskim agonistima kratkog djelovanja.
English: Candida infection in the oropharynx is due to active substance deposition.
Croatian: Kandidijaza orofarinksa uzrokovana je odlaganjem djelatne tvari.
English: Hold your inhaler with the semi-transparent wine red mouthpiece cover at the bottom.
Croatian: 1. Držite svoj inhalator s poluprozirnim poklopcem nastavka za usta u boji crvenog vina prema dolje.
English: The safety and efficacy of Budesonide/Formoterol Teva in children, 12 years and younger and adolescents, 13 to 17 years of age has not yet been established.
Croatian: Sigurnost i djelotvornost lijeka Budezonid/Formoterol Teva u djece stare 12 godina i mlađe, te u adolescenata, od 13 do 17 godina nisu još ustanovljene.
English: When it is appropriate to titrate down to a lower strength than is available for Budesonide/Formoterol Teva, a change to an alternative fixed-dose combination of budesonide and formoterol fumarate containing a lower dose of the inhaled corticosteroid is required.
Croatian: Kad je primjereno titriranje doze na nižu jačinu od one koja je dostupna u inhalatoru Budezonid/Formoterol Teva, potrebna je promjena na drugi kombinirani lijek s fiksnom dozom budezonida i formoterol fumarata, koji sadrži nižu dozu inhalacijskog kortikosteroida.
English: Very rare side effects: may affect up to 1 in 10,000 people
Croatian: Vrlo rijetke nuspojave: mogu se javiti kod do 1 na 10 000 osoba
English: How to store Budesonide/Formoterol Teva
Croatian: Kako čuvati Budezonid/Formoterol Teva
English: An increase in the incidence of pneumonia, including pneumonia requiring hospitalisation, has been observed in patients with COPD receiving inhaled corticosteroids.
Croatian: U bolesnika s KOPB-om koji su primali inhalacijske kortikosteroide zabilježeno je povećanje incidencije pneumonije, uključujući pneumoniju koja je zahtijevala bolničko liječenje.
English: • Pneumonia (infection to the lung) in COPD patients.
Croatian: • Upala pluća (infekcija pluća) u bolesnika s KOPB-om (česta nuspojava)
English: Budesonide/Formoterol Teva 320 micrograms/9 micrograms inhalation powder
Croatian: Budezonid/Formoterol Teva 320 mikrograma/9 mikrograma prašak inhalata
English: The inhaler is white with a semi-transparent wine red mouthpiece cover.
Croatian: Inhalator je bijele boje s poluprozirnim poklopcem nastavka za usta koji je boje crvenog vina.
English: If any of the above applies to you, or if you are not sure, talk to your doctor, pharmacist or nurse before using Budesonide/Formoterol Teva .
Croatian: Ako se bilo što od gore navedenog odnosi na Vas ili niste sigurni, prije uporabe lijeka Budezonid/Formoterol
English: How to store Budesonide/Formoterol Teva (page 21) 6.
Croatian: Kako čuvati Budezonid/Formoterol Teva (stranica 21) Sadržaj pakiranja i druge informacije (stranica 22)
English: Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Ireland Teva Pharmaceuticals Europe B.V., Swensweg 5, 2031 GA Haarlem, Netherlands Teva Operations Sp. Z o.o ul, Mogilska 80; 31-546 Krakow, Poland.
Croatian: Norton (Waterford) Limited T/A Teva Pharmaceuticals Irska Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Irska
English: Rare side effects: may affect up to 1 in 1,000 people
Croatian: Rijetke nuspojave: mogu se javiti kod do 1 na 1000 osoba
English: • If you are using Budesonide/Formoterol Teva for asthma, your doctor will want to regularly check your symptoms.
Croatian: Teva za astmu, Vaš liječnik će tražiti redovitu kontrolu vaših simptoma.
English: EXP Use the product within 6 months of removing from foil wrapping.
Croatian: Rok valjanosti Lijek upotrijebite u roku od 6 mjeseci nakon vađenja iz folije.
English: Each Budesonide/Formoterol Teva inhaler contains 120 inhalations and has a white body with a semitransparent wine red mouthpiece cover.
Croatian: Teva sadrži 120 inhalacija i ima bijelo tijelo s poluprozirnim poklopcem nastavka za usta boje crvenog vina.
English: Each Budesonide/Formoterol Teva inhaler contains 60 inhalations and has a white body with a semitransparent wine red mouthpiece cover.
Croatian: Teva sadrži 60 inhalacija i ima bijelo tijelo s poluprozirnim poklopcem nastavka za usta boje crvenog vina.
English: Tell your doctor if you have any of the following while taking Budesonide/Formoterol Teva they could be symptoms of a lung infection:
Croatian: Teva pojavi bilo koja od sljedećih nuspojava - može se raditi o simptomima infekcije pluća:
English: A randomised, open-label placebo study was performed in children and adolescents with asthma (aged 6-17 years), adults with asthma (aged 18-45 years), adults with chronic obstructive pulmonary disease (COPDaged >50 years) and healthy volunteers (aged 18-45 years) to evaluate the peak inspiratory flow rate (PIFR) and other related inhalation parameters following inhalation from a Spiromax device (containing placebo) compared with inhalation from an already marketed multi-dose dry powder inhaler device (containing placebo).
Croatian: > 50 godina) i zdravim dobrovoljcima (u dobi od 1845 godina) za procjenu brzine vršnog inspiratornog protoka (eng. peak inspiratory flow rate, PIFR) i drugih povezanih inhalacijskih parametara nakon inhalacije iz inhalatora Spiromax (koji sadrži placebo) u usporedbi s inhalacijom iz već na tržištu dostupnog inhalatora s više doza suhog praška (koji sadrži placebo).
English: How to store Budesonide/Formoterol Teva (page 19) 6.
Croatian: Kako čuvati Budezonid/Formoterol Teva (stranica 19) Sadržaj pakiranja i druge informacije (stranica 19)
English: Once asthma symptoms are controlled, consideration may be given to gradually reducing the dose of Budesonide/Formoterol Teva .
Croatian: Kada su simptomi astme kontrolirani, može se razmotriti postupno smanjenje doze lijeka Budezonid/Formoterol Teva.
English: Budesonide/Formoterol Teva 320 micrograms/9 micrograms inhalation powder budesonide/formoterol fumarate dihydrate
Croatian: Budezonid/Formoterol Teva 320 mikrograma/9 mikrograma prašak inhalata budezonid/ formoterolfumarat dihidrat
English: Budesonide/Formoterol Teva 160 micrograms / 4.5 micrograms inhalation powder
Croatian: Teva 160 mikrograma/4,5 mikrograma prašak inhalata
English: Each delivered dose (the dose that leaves the mouthpiece of the Spiromax) contains 160 micrograms of budesonide and 4.5 micrograms of formoterol fumarate dihydrate.
Croatian: Jedna primijenjena doza (doza koja izlazi iz nastavka za usta inhalatora Spiromax) sadrži 160 mikrograma budezonida i 4,5 mikrograma formoterolfumarat dihidrata.
English: Each delivered dose (the dose that leaves the mouthpiece of the Spiromax) contains 320 micrograms of budesonide and 9 micrograms of formoterol fumarate dihydrate.
Croatian: Jedna primijenjena doza (doza koja izlazi iz nastavka za usta inhalatora Spiromax) sadrži 320 mikrograma budezonida i 9 mikrograma formoterol fumarat dihidrata.
English: Patients should be reassessed regularly by their prescriber/health care provider so that the dose of Budesonide/Formoterol Teva remains optimal.
Croatian: Bolesnike mora redovito procijenjivati liječnik koji im propisuje lijekove/pružatelj zdravstvene skrbi kako bi doza inhalatora Budezonid/Formoterol
English: Each delivered (inhaled) dose contains 160 micrograms of budesonide and 4.5 micrograms of formoterol fumarate dihydrate.
Croatian: Jedna primijenjena (inhalirana) doza sadrži 160 mikrograma budezonida i 4,5 mikrograma formoterolfumarat dihidrata.
English: Once asthma symptoms are controlled, consideration may be given to gradually reducing the dose of Budesonide/Formoterol Teva.
Croatian: Nakon što se postigne kontrola simptoma astme, može se razmotriti postupno smanjenje doze lijeka Budezonid/Formoterol Teva.
English: Each delivered (inhaled) dose contains 320 micrograms of budesonide and 9 micrograms of formoterol fumarate dihydrate.
Croatian: Jedna primijenjena (inhalirana) doza sadrži 320 mikrograma budezonida i 9 mikrograma formoterolfumarat dihidrata.
English: For a fixed-dose combination therapy of budesonide and formoterol fumarate dihydrate or the concomitant treatment with formoterol and budesonide, no clinical data on exposed pregnancies are available.
Croatian: Nema dostupnih kliničkih podataka o trudnoćama izloženim terapiji kombinacijom fiksne doze budezonida i formoterolfumarat dihidrata ili istodobnom liječenju formoterolom i budezonidom.
English: What you need to know before you use Budesonide/Formoterol Teva (page 5) 3.
Croatian: Što je Budezonid/Formoterol Teva i za što se koristi (stranica 3) Što morate znati prije nego počnete primjenjivati Budezonid/Formoterol Teva (stranica 5) Kako primjenjivati Budezonid/Formoterol Teva (stranica 8) Moguće nuspojave (stranica 16)
English: Budesonide/Formoterol Teva is an inhalation powder.
Croatian: Teva je prašak inhalata.
English: Patients should be reminded to take their Budesonide/Formoterol Teva maintenance dose as prescribed, even when asymptomatic.
Croatian: Bolesnike se mora podsjetiti da svoju dozu održavanja lijekom Budezonid/Formoterol
English: Budesonide/Formoterol Teva is not indicated for use in children, 12 years of age and younger or adolescents, 13 to 17 years of age.
Croatian: Budezonid/Formoterol Teva nije indiciran za primjenu u djece, u dobi od 12 godina i mlađe, niti za adolescente u dobi od 13 do 17 godina.
English: Budesonide/Formoterol Teva 160 micrograms / 4.5 micrograms inhalation powder budesonide/ formoterol fumarate dihydrate
Croatian: Teva 160 mikrograma/4,5 mikrograma prašak inhalata budezonid/ formoterolfumarat dihidrat
English: The most common symptoms that may occur after if you use more Budesonide/Formoterol Teva than you should are trembling, headache or a rapid heartbeat.
Croatian: Najčešći simptomi koji se mogu pojaviti ako koristite veću količinu lijeka Budezonid/Formoterol
English: Budesonide/Formoterol Teva is NOT indicated for use in children 12 years of age and younger or adolescents 13 to 17 years of age.
Croatian: Budezonid/Formoterol Teva NIJE indiciran za primjenu u djece s navršenih 12 godina i mlađu niti za adolescente u dobi od 13 do 17 godina.
English: Budesonide/Formoterol Teva is indicated in adults 18 years of age and older only.
Croatian: Teva indiciran je samo u odraslih u dobi od 18 godina i starijih.
English: Asthma Using Budesonide/Formoterol Teva and a separate ‘reliever inhaler'
Croatian: Primjena lijeka Budezonid/Formoterol Teva i zasebnog 'inhalatora za brzo ublažavanje simptoma'
English: Budesonide/Formoterol Teva 160 mcg/4.5 mcg inhalation powder budesonide/formoterol fumarate dihydrate
Croatian: Teva 160 μg/4,5 μg prašak inhalata budezonid/formoterolfumarat dihidrat